These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13423742)

  • 21. [ON THE PATHOGENESIS OF INTRAPERITONEAL INFECTION WITH BORDETELLA PERTUSSIS IN MICE. 9. STUDIES ON THE ROLE AND IMMUNOGENIC NATURE OF PURIFIED AGGLUTINOGENS AND TOXIN FRACTIONS IN INTRAPERITONEAL INFECTION].
    ISHII T
    Nihon Saikingaku Zasshi; 1963 Dec; 18():458-64. PubMed ID: 14151195
    [No Abstract]   [Full Text] [Related]  

  • 22. The role and specificity of bordetella lipopolysaccharide in immune reactions.
    Pusztai Z; Csizér Z; Joó I
    Z Immunitatsforsch Allerg Klin Immunol; 1971; 141(2):129-40. PubMed ID: 4323220
    [No Abstract]   [Full Text] [Related]  

  • 23. TOLERANCE INDUCTION AND SKIN GRAFT PROLONGATION BY COMPETING ANTIGENS.
    TERINO EO; MILLER J; GLEEN WW
    Surgery; 1964 Jul; 56():256-65. PubMed ID: 14174744
    [No Abstract]   [Full Text] [Related]  

  • 24. Overcoming of endotoxin--mediated immunosuppression by Bordetella pertussis.
    Finger H; Fölmer I; Plager L; Henseling M
    Experientia; 1972 May; 28(5):562-3. PubMed ID: 4339277
    [No Abstract]   [Full Text] [Related]  

  • 25. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A soluble antigen of phase 1 Hemophilus pertussis. I. Mouse protection test of filtrate or supernatant of cultures in a medium without soluble starch or carbon particles.
    KUWAJIMA Y; MASUI M; ASANO A; MATSUI T
    J Immunol; 1956 Mar; 76(3):175-80. PubMed ID: 13306951
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the k antigen of Haemophilus pertussis; especially on the so-called S-antigen.
    SOMEYA S; KANEKO Y
    Jpn J Med Sci Biol; 1955 Apr; 8(2):99-108. PubMed ID: 13278103
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pertussis toxin and cross-reactive antigens in dynamics of Bordetella pertussis cultivation].
    Basnak'ian IA; Aleksakhina NN; Siundiukova SA; Zakharova NS; Zaĭtsev EM; Iastrebova NE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):54-7. PubMed ID: 18038548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface antigens of Haemophilus pertussis.
    GUERAULT A; MAITLAND HB
    Nature; 1958 Jan; 181(4602):122-3. PubMed ID: 13493619
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine].
    Zaĭtsev EM; Poddubikov AV; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Bazhanova IG; Plekhanova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):20-4. PubMed ID: 24738289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE NEUTRALIZATION OF B. PERTUSSIS TOXIN IN A TISSUE CULTURE.
    STRIZOVA V; TRLIFAJOVA J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():428-32. PubMed ID: 14238941
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the immunochemical relationships of Bordetella species].
    Barber C; Andreesco V; Pozsgi N; Caffé I
    Pathol Microbiol (Basel); 1967; 30(1):94-102. PubMed ID: 4291706
    [No Abstract]   [Full Text] [Related]  

  • 34. Crossed immunoelectrophoretic analysis of Bordetella pertussis antigens and of corresponding antibodies in human sera.
    Hertz JB; Hølby N; Andersen V; Baekgaard P
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):386-94. PubMed ID: 187009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical studies on cellular components of Bordetella pertussis. I. Purification and properties of agglutinogen.
    ONOUE K; KITAGAWA M; YAMAMURA Y
    J Bacteriol; 1961 Nov; 82(5):648-56. PubMed ID: 14482070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of passive transfer of protective antibodies against H. pertussis earlier than agglutinins are detectable.
    ANDERSEN EK
    Acta Pathol Microbiol Scand; 1955; 37(2):189-95. PubMed ID: 13258227
    [No Abstract]   [Full Text] [Related]  

  • 37. [Investigations on toxin of Hemophilus pertussis].
    TRUSHINA-TUMANOVA EF; MAMAEVA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):38-40. PubMed ID: 13282451
    [No Abstract]   [Full Text] [Related]  

  • 38. Serological study of Bordetella pertussis and related species.
    ELDERING G; HORNBECK C; BAKER J
    J Bacteriol; 1957 Aug; 74(2):133-6. PubMed ID: 13475208
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electromyographic studies on the effects of Hemophilus pertussis on the central nervous system. II. Electromyogram of the intercostal muscles of dogs with intraspinal administration of the toxin of Hemophilus pertussis, type I].
    YAMANAKA Y
    Paediatr Jpn; 1961 Jun; 65():657-60. PubMed ID: 13787172
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of the passive immunization on the sensitizing activity of Bordetella pertussis. I. Increase of sensitivity to repeated homologous antigen administrations].
    Sumarokov AA; Kulikova IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1965 May; 42(5):33-8. PubMed ID: 4161435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.